8,656 Shares in Docusign Inc. $DOCU Bought by EP Wealth Advisors LLC

EP Wealth Advisors LLC purchased a new position in Docusign Inc. (NASDAQ:DOCU) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,656 shares of the company’s stock, valued at approximately $385,000.

Several other institutional investors have also added to or reduced their stakes in DOCU. Modus Advisors LLC purchased a new position in shares of Docusign in the fourth quarter worth about $27,000. Torren Management LLC purchased a new stake in Docusign during the 4th quarter valued at about $28,000. Cary Street Partners Investment Advisory LLC boosted its holdings in Docusign by 309.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company’s stock valued at $38,000 after acquiring an additional 424 shares during the period. Basepoint Wealth LLC purchased a new stake in Docusign during the 4th quarter valued at about $39,000. Finally, WealthCollab LLC grew its position in Docusign by 372.4% during the 1st quarter. WealthCollab LLC now owns 855 shares of the company’s stock worth $41,000 after acquiring an additional 674 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Docusign Trading Down 3.2%

Docusign stock opened at $60.54 on Wednesday. The firm has a market cap of $11.56 billion, a P/E ratio of 39.31, a P/E/G ratio of 1.83 and a beta of 0.87. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The firm has a 50-day moving average of $52.28 and a 200-day moving average of $48.83.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.10. The company had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.Docusign’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.90 EPS. Research analysts forecast that Docusign Inc. will post 2.04 earnings per share for the current fiscal year.

Insider Transactions at Docusign

In related news, CFO Blake Jeffrey Grayson sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the transaction, the chief financial officer owned 126,429 shares in the company, valued at $7,585,740. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $273,240.00. Following the completion of the sale, the executive directly owned 89,972 shares of the company’s stock, valued at $4,097,324.88. The trade was a 6.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 91,695 shares of company stock worth $4,376,002. Corporate insiders own 0.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on DOCU shares. UBS Group set a $60.00 price target on Docusign in a research note on Friday, June 5th. Citizens Jmp reissued a “market outperform” rating and set a $86.00 price objective on shares of Docusign in a research note on Tuesday, August 18th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Friday, June 5th. BTIG Research cut their target price on shares of Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Finally, Wedbush decreased their target price on shares of Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Four research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $60.27.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.